Targeting Mitochondria in Aging‐Related Diseases: Therapeutic Potential and Obstacles
MedComm · 2026-06 · 7 (6)
DOI: 10.1002/mco2.70790 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 04.06.2026. Verfasst von Zijie Xiang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics The First Affiliated Hospital of Soochow University Suzhou Jiangsu China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 469 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Aging is a complex biological process characterized by the functional decline of multiple cellular organelles, with mitochondrial dysfunction emerging as a predominant hallmark. Alterations in mitochondria within senescent cells primarily encompass two interrelated aspects: intrinsic mitochondrial dysfunction and compromised mitochondrial quality control systems, including mitophagy, dynamics, and biogenesis. However, a comprehensive synthesis that bridges mechanistic insights into mitochondrial dysfunction with an analysis of therapeutic obstacles remains lacking. Here, we systematically summarized the pathways leading to mitochondrial dysfunction in aging and deeply analyzed how this dysregulation, including mitochondrial DNA instability and mitochondria driving inflammation through the cGAS–STING pathway, contributed to the etiology of aging‐related diseases, including muscle, bone, neurodegeneration, cardiovascular, and metabolic diseases. Additionally, we analyzed a series of mitochondrial targeted treatment strategies, from metabolism and kinetic regulation to disease‐specific intervention and emerging technologies, such as mitochondrial transplantation and mitochondrial DNA base editing. Finally, we emphasized the key obstacles that must be overcome for clinical transformation, including tissue‐specific mitochondrial heterogeneity. By combining the basic mechanism with the development of treatment and its potential challenges, this review provides a key perspective for promoting the emerging field of mitochondrial medicine to intervene in aging‐related pathology more accurately and effectively.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics The First Affiliated Hospital of Soochow University Suzhou Jiangsu China.
- Department of Breast Surgery Changhai Hospital Naval Medical University Shanghai China.
- Department of Orthopedics The First Affiliated Hospital of USTC University of Science and Technology of China (USTC) Hefei Anhui China.
- Department of Hematology The First People's Hospital of Yunnan Province Kunming China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xiang, Z., Chen, Y., Liu, X., Lu, H., Yang, Y., Xing, L., Zhang, Y., Lang, C., Zhang, S., Zhao, S., Hong, Y., Bai, J., & Qiao, Y. (2026). Targeting Mitochondria in Aging‐Related Diseases: Therapeutic Potential and Obstacles. MedComm, 7(6). https://doi.org/10.1002/mco2.70790
Vancouver
Xiang Z, Chen Y, Liu X, Lu H, Yang Y, Xing L, et al. Targeting Mitochondria in Aging‐Related Diseases: Therapeutic Potential and Obstacles. MedComm. 2026;7(6). doi:10.1002/mco2.70790
BibTeX
@article{Xiang2026,
author = {Xiang, Zijie and Chen, Yu and Liu, Xishui and Lu, Haowen and Yang, Yuqing and Xing, Lei and Zhang, Yu and Lang, Chuandong and Zhang, Siming and Zhao, Shixiang and Hong, Youzhi and Bai, Jiaxiang and Qiao, Yusen},
title = {Targeting Mitochondria in Aging‐Related Diseases: Therapeutic Potential and Obstacles},
journal = {MedComm},
year = {2026},
volume = {7},
number = {6},
doi = {10.1002/mco2.70790}
}
EUVIMED